Dover has entered right into a definitive agreement to accumulate Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will broaden Dover’s biopharma single-use production providing, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in pressure gauge 10 bar , Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in income through the full 12 months 2022.
When the deal closes, Malema will become part of the PSG business unit within Dover’s Pumps & Process Solutions section.
“We see an amazing long-term progress alternative in the bioprocessing trade pushed by a robust and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of extra efficient single-use manufacturing processes helps a robust outlook for our offerings of single-use elements to end-customers. เกจวัดแรงดัน imagine that pairing Malema’s expertise with our present portfolio of single-use pumps for biopharma processing will significantly enhance the accuracy and worth proposition of our options to our clients.”
“We are methodically building out our biopharma platform through proactive capacity additions, new product development, and opportunistic acquisitions of highly-attractive niche element applied sciences,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and further strengthens our sensor portfolio with new proprietary expertise. In addition to enticing biopharma functions, we anticipate robust growth within the semiconductor space on the capability growth and re-shoring tailwinds.”
Share